{"id":"https://openalex.org/W7127590708","doi":"https://doi.org/10.1158/1078-0432.c.8289899","title":"Data from Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring","display_name":"Data from Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring","publication_year":2026,"publication_date":"2026-02-04","ids":{"openalex":"https://openalex.org/W7127590708","doi":"https://doi.org/10.1158/1078-0432.c.8289899"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.8289899","doi":"https://doi.org/10.1158/1078-0432.c.8289899","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.8289899","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.8289899","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104329588","display_name":"Jiayao Ni","orcid":"https://orcid.org/0009-0004-4845-3006","observed_orcids":["https://orcid.org/0009-0004-4845-3006"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiayao Ni","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-4845-3006","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125091965","display_name":"Yi Sun","orcid":"https://orcid.org/0000-0002-3818-1260","observed_orcids":["https://orcid.org/0000-0002-3818-1260"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi Sun","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3818-1260","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101925055","display_name":"Hao Cheng","orcid":"https://orcid.org/0000-0001-6621-7614","observed_orcids":["https://orcid.org/0000-0001-6621-7614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao Cheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6621-7614","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125041291","display_name":"Xinyuan Bai","orcid":"https://orcid.org/0009-0006-9737-2880","observed_orcids":["https://orcid.org/0009-0006-9737-2880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinyuan Bai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-9737-2880","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122772081","display_name":"Fan Tong","orcid":"https://orcid.org/0009-0009-2192-3377","observed_orcids":["https://orcid.org/0009-0009-2192-3377"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fan Tong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-2192-3377","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125063205","display_name":"Xing Zhang","orcid":"https://orcid.org/0009-0004-9133-6833","observed_orcids":["https://orcid.org/0009-0004-9133-6833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xing Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-9133-6833","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124974836","display_name":"Xiaoxuan Wang","orcid":"https://orcid.org/0009-0006-2844-318X","observed_orcids":["https://orcid.org/0009-0006-2844-318X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxuan Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-2844-318X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080252955","display_name":"Liang Mao","orcid":"https://orcid.org/0000-0002-7112-9421","observed_orcids":["https://orcid.org/0000-0002-7112-9421"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liang Mao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7112-9421","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125063038","display_name":"Gang Li","orcid":"https://orcid.org/0009-0002-1292-1723","observed_orcids":["https://orcid.org/0009-0002-1292-1723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1292-1723","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146858704","display_name":"Shanshan Shen","orcid":"https://orcid.org/0000-0002-1543-1749","observed_orcids":["https://orcid.org/0000-0002-1543-1749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shanshan Shen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1543-1749","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091704392","display_name":"Weiwei Kong","orcid":"https://orcid.org/0009-0001-8342-0638","observed_orcids":["https://orcid.org/0009-0001-8342-0638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weiwei Kong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-8342-0638","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125063767","display_name":"Jian He","orcid":"https://orcid.org/0000-0001-8140-4610","observed_orcids":["https://orcid.org/0000-0001-8140-4610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jian He","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8140-4610","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124974098","display_name":"Aimei Li","orcid":"https://orcid.org/0009-0003-2020-8909","observed_orcids":["https://orcid.org/0009-0003-2020-8909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aimei Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-2020-8909","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125057161","display_name":"Jun Chen","orcid":"https://orcid.org/0000-0003-3905-4615","observed_orcids":["https://orcid.org/0000-0003-3905-4615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3905-4615","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125023552","display_name":"Min Tang","orcid":"https://orcid.org/0009-0002-1619-1983","observed_orcids":["https://orcid.org/0009-0002-1619-1983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Tang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1619-1983","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018537653","display_name":"Bozhu Chen","orcid":"https://orcid.org/0000-0003-0977-2616","observed_orcids":["https://orcid.org/0000-0003-0977-2616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bozhu Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0977-2616","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125001421","display_name":"Qi Li","orcid":"https://orcid.org/0000-0003-2087-3610","observed_orcids":["https://orcid.org/0000-0003-2087-3610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2087-3610","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125043595","display_name":"Qing Gu","orcid":"https://orcid.org/0000-0002-1112-790X","observed_orcids":["https://orcid.org/0000-0002-1112-790X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qing Gu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1112-790X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086148906","display_name":"Zhongyu Lu","orcid":"https://orcid.org/0009-0000-6813-7650","observed_orcids":["https://orcid.org/0009-0000-6813-7650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhongyu Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-6813-7650","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021087145","display_name":"Dongsheng Chen","orcid":"https://orcid.org/0009-0003-8626-9827","observed_orcids":["https://orcid.org/0009-0003-8626-9827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dongsheng Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-8626-9827","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103950900","display_name":"Huizi Sha","orcid":"https://orcid.org/0000-0001-6820-8885","observed_orcids":["https://orcid.org/0000-0001-6820-8885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huizi Sha","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6820-8885","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124989796","display_name":"Baorui Liu","orcid":"https://orcid.org/0000-0002-2539-7732","observed_orcids":["https://orcid.org/0000-0002-2539-7732"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Baorui Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2539-7732","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108999846","display_name":"Yudong Qiu","orcid":"https://orcid.org/0009-0007-8227-9322","observed_orcids":["https://orcid.org/0009-0007-8227-9322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yudong Qiu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-8227-9322","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5125092804","display_name":"Juan Du","orcid":"https://orcid.org/0009-0001-8477-573X","observed_orcids":["https://orcid.org/0009-0001-8477-573X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Du","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-8477-573X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tislelizumab","display_name":"tislelizumab","score":0.949999988079071},{"id":"https://openalex.org/keywords/hypofractionated-radiotherapy","display_name":"hypofractionated radiotherapy","score":0.9779999852180481},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9470000267028809},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/borderline-resectable-pancreatic-cancer","display_name":"borderline resectable pancreatic cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/locally-advanced-pancreatic-cancer","display_name":"locally advanced pancreatic cancer","score":1.0},{"id":"https://openalex.org/keywords/conversion-therapy","display_name":"conversion therapy","score":0.902999997138977},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.593999981880188},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6290000081062317},{"id":"https://openalex.org/keywords/resectability","display_name":"resectability","score":0.7089999914169312},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7200000286102295},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9240999817848206},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6101999878883362},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5805000066757202},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5142999887466431},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.48539999127388},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4832000136375427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4756999909877777},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.45980000495910645},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.45089998841285706},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4260999858379364},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4066999852657318},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.39169999957084656},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3366999924182892},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32510000467300415},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3246000111103058},{"id":"https://openalex.org/C2778764654","wikidata":"https://www.wikidata.org/wiki/Q9618","display_name":"Pancreas","level":2,"score":0.3034999966621399},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.2741999924182892},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.2632000148296356},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.2517000138759613},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.2517000138759613}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.8289899","doi":"https://doi.org/10.1158/1078-0432.c.8289899","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.8289899","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.8289899","doi":"https://doi.org/10.1158/1078-0432.c.8289899","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.8289899","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416910960","https://openalex.org/W7221543237","https://openalex.org/W4379333692","https://openalex.org/W4400408326","https://openalex.org/W7162495376","https://openalex.org/W4400272978","https://openalex.org/W2914490761","https://openalex.org/W4401326325","https://openalex.org/W4410815221","https://openalex.org/W4310949323"],"abstract_inverted_index":{"AbstractPurpose:":[0],"The":[1,110,175,233],"optimal":[2],"conversion":[3],"treatment":[4,89,256],"for":[5,96,151,253],"patients":[6,45,59,78,107,147,155,163,170,188,206],"with":[7,38,46,60,164,171,243,258],"borderline":[8],"resectable":[9],"pancreatic":[10,15],"cancer":[11,16],"or":[12],"locally":[13],"advanced":[14],"(BRPC/LAPC)":[17],"remains":[18],"unclear.":[19],"In":[20],"this":[21],"study,":[22],"we":[23],"present":[24],"the":[25,83,185],"efficacy":[26],"and":[27,51,132,168,184,227],"safety":[28,246],"results":[29],"of":[30,187],"a":[31,91,244],"phase":[32,54],"II":[33,55],"trial":[34,56],"evaluating":[35],"tislelizumab":[36,70],"combined":[37],"hypofractionated":[39],"radiotherapy":[40,81],"plus":[41,71],"nab-paclitaxel/gemcitabine":[42,72],"(THAG)":[43],"in":[44,74,204],"BRPC/LAPC":[47,61],"(ChiCTR2000032955,":[48],"NCT05634564).":[49],"Patients":[50],"Methods:":[52],"This":[53],"enrolled":[57],"56":[58],"(BRPC:":[62],"17,":[63],"30.4%;":[64],"LAPC:":[65],"39,":[66],"69.6%).":[67],"Participants":[68],"received":[69,79],"(AG)":[73],"21-day":[75],"cycles.":[76],"Nonprogressing":[77],"concurrent":[80],"during":[82],"third":[84],"chemotherapy":[85],"cycle.":[86],"After":[87],"four":[88],"cycles,":[90],"multidisciplinary":[92],"team":[93],"assessed":[94],"eligibility":[95],"radical":[97,159],"surgery.":[98],"Dynamic":[99,208,248],"biomolecular":[100],"profiling":[101],"was":[102,114,125,137,192],"performed.":[103],"Results:":[104],"Fifty-six":[105],"eligible":[106],"were":[108],"enrolled.":[109],"objective":[111],"response":[112],"rate":[113,178],"51.8%":[115],"[95%":[116,140],"confidence":[117],"interval":[118],"(CI),":[119],"38.0%\u201365.3%].":[120],"Median":[121],"progression-free":[122],"survival":[123,135],"(mPFS)":[124],"13.2":[126],"months":[127,139,194],"(95%":[128,181,195],"CI,":[129,141,182,196],"11.6\u201319.4":[130],"months),":[131],"median":[133],"overall":[134],"(mOS)":[136],"21.3":[138],"18.8\u2013not":[142],"reached":[143,179],"(NR)].":[144],"Among":[145],"30":[146],"who":[148,189],"met":[149],"criteria":[150],"surgical":[152],"resectability,":[153],"22":[154],"(22/56,":[156],"39.3%)":[157],"underwent":[158,190],"resection,":[160],"comprising":[161],"nine":[162],"BRPC":[165],"(9/17,":[166],"52.9%)":[167],"13":[169],"LAPC":[172],"(13/39,":[173],"33.3%).":[174],"margin-negative":[176],"resection":[177],"90.9%":[180],"70.8%\u201398.9%),":[183],"mOS":[186],"surgery":[191],"34.0":[193],"20.1\u2013NR).":[197],"Grade":[198],"\u22653":[199],"adverse":[200],"events":[201],"(AE)":[202],"occurred":[203],"33/56":[205],"(58.9%).":[207],"biomarker":[209,249],"exploration":[210],"revealed":[211],"that":[212],"baseline":[213],"IL6":[214],"level":[215],"(>5":[216],"pg/mL)":[217],"predicted":[218],"better":[219],"PFS.":[220],"Moreover,":[221],"circulating":[222],"tumor":[223],"DNA":[224],"(ctDNA)":[225],"status":[226],"clearance":[228],"demonstrated":[229],"superior":[230],"survival.":[231],"Conclusions:":[232],"THAG":[234],"regimen":[235],"as":[236],"preoperative":[237],"therapy":[238],"showed":[239],"encouraging":[240],"clinical":[241],"activity":[242],"manageable":[245],"profile.":[247],"findings":[250],"reveal":[251],"potential":[252],"guiding":[254],"precision":[255],"strategies":[257],"THAG.":[259]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-02-06T00:00:00"}